Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018, Johns Hopkins University Bloomberg School of Public Health
Credit: CC0 Public Domain

Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating lower back pain, a study led by researchers at Johns Hopkins Bloomberg School of Public Health has found. 

The Bloomberg School researchers looked at Medicaid, Medicare and major commercial ' 2017 coverage policies for non-drug options for treating chronic lower back pain—a common pain condition that is often treated inappropriately with . They found that insurers have inconsistent terms for non-drug treatments, and provide little or no coverage for interventions such as acupuncture and psychological counseling, treatments which do have some scientific backing. 

A key finding was that insurers did not have clear and consistent coverage policies for several lower back pain treatments that have been found effective in some studies. Acupuncture, for example, was expressly covered by only five of the 45 examined plans. 

"This study reveals an important opportunity for insurers to broaden and standardize their coverage of non-drug pain treatments to encourage their use as safer alternatives to opioids," says study senior author Caleb Alexander, MD, MS, associate professor of epidemiology at the Bloomberg School. 

The study, to be published Oct. 5 in the online journal JAMA Network Open, follows a complementary study by the same research team of major insurers' policies on prescription drugs for pain, published in the same journal in June. The two studies are the most comprehensive of their kind, and were conducted with funding and technical assistance from the U.S. Department of Health and Human Services (HHS), the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). 

CDC officials estimate that 49,031 Americans died from overdoses in the 12-month period ending in December 2017. In 2016, more than 40 percent of those deaths were due to prescription opioids. This epidemic has been encouraged by a several-fold increase in opioid prescriptions since the turn of the century—most of which are thought to be medically unnecessary. Current CDC guidelines note that "Non-opioid therapy is preferred for chronic pain outside of active cancer, palliative, and end-of-life care." HHS has urged insurers to design their coverage policies accordingly. 

To gauge how far insurers have moved towards this goal, Alexander and colleagues examined 15 Medicaid, 15 Medicare Advantage and 15 major commercial insurer plans for 2017 covering non-drug treatments for lower back pain. The 45 plans were applicable in 16 states, chosen for the diversity of their geography, wealth and opioid-epidemic impact. 

Of the fifteen Medicaid plans assessed for psychological coverage, just three plans covered psychological interventions. "We were perplexed by the absence of coverage language on psychological interventions," Alexander says. "It's hard to imagine that insurers wouldn't cover that." 

Even for , an important and well-established method of relieving lower back pain that was covered by nearly all plans, specific coverage policies were inconsistent. "Some plans covered two visits, some six, some 12; some allowed you to refer yourself for treatment, while others required referral by a doctor," Alexander says. "That variation indicates a lack of consensus among insurers regarding what model coverage should be, or a lack of willingness to pay for it." 

The researchers interviewed 43 executives representing the evaluated plans; these individuals indicated that their organizations have been trying to expand access to non-drug therapies in response to the opioid epidemic. Overall, however, their remarks suggested that insurers were not yet doing enough to coordinate non-drug and drug coverage policies, such as requiring patients to try physical therapy for their lower back before covering long-term opioids. 

Alexander emphasizes that while many of the covered non-drug therapies, such as acupuncture and chiropractic interventions, might seem untested, there is significant evidence for their effectiveness in treating

The findings, to Alexander and colleagues, suggest that there is still a lot of room for improvement in coverage policies, particularly an expansion and standardization of non-drug coverage and policy terms—a change that should encourage more use of non-drug treatments by patients before they resort to opioid painkillers. 

"In the last few years we have seen many insurers modifying their policies to reduce the vast overuse of opioids, but clearly we still have a long way to go," says Alexander.

Explore further: Health insurance plans may be fueling opioid epidemic

More information: "Coverage of Non-Pharmacologic Treatments for Lower Back Pain Among Public and Private Insurers in the United States" JAMA Network Open (2018).

Related Stories

Health insurance plans may be fueling opioid epidemic

June 22, 2018
Health care insurers including Medicare, Medicaid and major private insurers have not done enough to combat the opioid epidemic, suggests a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

Coverage policies compared for back pain medications

June 25, 2018
(HealthDay)—There are opportunities for recalibrating the role of opioids in pain care, including expanding access to opioid alternatives through coverage and reimbursement policies, according to a study published online ...

States ask insurers to prioritize non-opioid pain treatment

September 18, 2017
Attorneys general representing the majority of states are asking the insurance industry to encourage pain treatment through means other than prescriptions for opioid painkillers.

Poorest Americans most likely to have used prescription opioids—and most users view opioids positively

September 12, 2018
Among older Americans, the poorest are the most likely to have used prescription opioids, according to a University at Buffalo study providing new insights into unexplored contours of the opioid crisis.

Nonaddictive drug compound could replace opioids for chronic pain sufferers

October 5, 2018
A new nonaddictive drug compound discovered by Purdue University researchers could lead to the treatment of chronic pain without the need to rely on opioids, just as a bipartisan package of bills moves through the U.S. House ...

Physical therapy could lower need for opioids, but lack of money and time are hurdles

June 22, 2018
Physical therapists help people walk again after a stroke and recover after injury or surgery, but did you know they also prevent exposure to opioids? This is timely, given we are in a public health emergency related to an ...

Recommended for you

Research finds opioids may help chronic pain, a little

December 18, 2018
Use of opioids for patients with chronic, non-cancer pain may help, but not a lot.

Early postpartum opioids linked with persistent usage

December 14, 2018
Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum ...

Early physical therapy can reduce risk, amount of long-term opioid use, study finds

December 14, 2018
Patients who underwent physical therapy soon after being diagnosed with pain in the shoulder, neck, low back or knee were approximately 7 to 16 percent less likely to use opioids in the subsequent months, according to a new ...

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.